Labcorp Drug Development Engager | Digital Event

Accelerate Time to Market & Widen Your Global Reach with Patient-Centric Decentralized Clinical Trials

Tuesday November 30, 2021 | Digital Event

9.00am JST to 11.00am JST

Accelerate Time to Market & Widen Your Global Reach with Patient-Centric

Decentralized Clinical Trials

In the world of COVID-19 and with the pressing need to rapidly evolve and optimize clinical trials to increase patient recruitment, engagement and retention at global scale, decentralized clinical trials (DCTs) are setting a new standard for how trials should be conducted.

This Labcorp Engager has been created as an exclusive online event to provide C-level Executives, Heads of Development and Clinical Operations Leaderships of Japan biopharma companies with the latest insights and
innovations on how to take an enterprise approach to seamlessly design and implement decentralized clinical trials. Learn new ways to broaden your global patient reach and diversity, streamline data collation and analysis, as well as accelerate time to market for new drugs and therapies.

WHO SHOULD ATTEND

This is an exclusive limited-attendance event for C-level Executives, Heads of Development and Clinical Operations Leaderships of Japan biopharma companies to identify emerging trends on how to maximize the resiliency of your DCT design and site set up, understand regulatory and protocol compliance requirements and how to make the process thoroughly patient-centric.

EXPERT SPEAKERS

ABOUT LABCORP DRUG DEVELOPMENT

LabcorpDD_Logo_200x200 (003)

Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With more than 70,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14.0 billion in FY2020.

Learn about Labcorp at www.labcorp.com, or follow us on LinkedIn and Twitter @Labcorp.